Both in Biotechnology
Candel Therapeutics vs Cullinan Therapeutics
Over the past year CADL returned +76.4% and CGEM returned +68.8%; their daily moves had a correlation of 0.35.
CADL +76.4% CGEM +68.8%Growth of $1, one year, split-adjusted
| Metric | CADL | CGEM |
|---|---|---|
| Price | $9.05 | $12.49 |
| Market cap | $692.5M | $803.8M |
| Today | +2.61% | −20.70% |
| 1 month | −8.3% | −23.1% |
| 6 months | +18.6% | −16.7% |
| Year to date | +60.2% | +20.7% |
| 1 year | +73.4% | +59.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $153.7M | $334.5M |
| Dividend yield | — | — |
| Volatility (60d) | 67.7% | 87.7% |
| Short % of float | 21.5% | 14.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).